bf/NASDAQ:TNDM_icon.jpeg

COM:TANDEMDIABETES

Tandem Diabetes Care, Inc.

  • Stock

Last Close

30.74

22/11 21:00

Market Cap

2.02B

Beta: -

Volume Today

1.23M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
8.30M
-
11.12M
34.07%
14.73M
32.43%
19.37M
31.51%
24.09M
24.39%
23.44M
2.70%
34.48M
47.09%
56.40M
63.54%
66.14M
17.27%
89.83M
35.83%
134.53M
49.75%
average payables
4.08M
-
8.47M
107.48%
16.85M
98.94%
19.22M
14.04%
20.90M
8.73%
28.63M
36.99%
26.26M
8.25%
17.77M
32.32%
22.92M
28.94%
41.88M
82.74%
52.66M
25.73%
average receivables
3.87M
-
6.48M
67.42%
10.85M
67.62%
12.61M
16.22%
15.98M
26.71%
27.99M
75.15%
40.89M
46.07%
64.39M
57.48%
96.46M
49.81%
112.72M
16.86%
110.14M
2.29%
book value per share
392.72
-
23.45
94.03%
21.95
6.41%
-1.94
108.83%
-5.13
164.82%
2.73
153.12%
3.33
22.18%
6.01
80.22%
6.87
14.47%
6.86
0.24%
4.83
29.61%
capex per share
-20.43
-
-1.97
90.37%
-2.02
2.60%
-2.92
44.71%
-1.01
65.52%
-0.06
93.84%
-0.33
438.34%
-0.53
58.53%
-0.37
29.52%
-0.67
79.43%
-0.79
18.62%
capex to depreciation
-1.90
-
-1.04
45.02%
-1.21
15.88%
-1.63
34.57%
-0.83
48.81%
-0.51
38.40%
-3.22
527.37%
-3.09
3.98%
-1.70
45.04%
-3.00
76.51%
-3.28
9.55%
capex to operating cash flow
0.13
-
0.07
40.72%
0.10
33.17%
0.15
46.94%
0.09
40.77%
0.36
315.16%
-0.47
229.92%
-1.31
180.73%
-0.21
83.87%
-0.85
303.14%
1.62
290.59%
capex to revenue
-0.21
-
-0.09
55.55%
-0.08
12.98%
-0.11
32.27%
-0.05
49.87%
-0.02
69.44%
-0.05
232.11%
-0.06
20.03%
-0.03
48.33%
-0.05
60.25%
-0.07
28.74%
cash per share
440.11
-
28.91
93.43%
24.59
14.96%
17.51
28.77%
2.50
85.74%
2.68
7.34%
3.02
12.50%
7.95
163.63%
9.90
24.53%
9.62
2.87%
7.20
25.11%
days of inventory on hand
165.08
-
126.13
23.59%
138.39
9.72%
127.54
7.84%
155.14
21.64%
77.22
50.23%
106.56
37.99%
97.60
8.41%
76.61
21.50%
104.47
36.36%
151.69
45.20%
days payables outstanding
37.59
-
154.48
311.01%
150.80
2.39%
116.29
22.88%
129.14
11.05%
135.00
4.54%
38.53
71.46%
27.27
29.23%
31.33
14.88%
52.40
67.24%
47.63
9.10%
days sales outstanding
66.67
-
56.17
15.75%
70.42
25.36%
48.40
31.27%
70.53
45.72%
69.86
0.95%
46.93
32.82%
60.14
28.15%
57.51
4.39%
52.26
9.12%
51.53
1.40%
debt to assets
0.23
-
0.28
19.57%
0.24
14.25%
0.70
196.27%
0.80
14.27%
0.06
-
0.32
409.89%
0.35
9.08%
0.40
14.72%
0.44
9.40%
debt to equity
0.32
-
0.54
66.14%
0.47
13.35%
-13.32
2,949.86%
-2.63
80.29%
0.10
-
0.62
496.24%
0.73
16.56%
0.95
31.36%
1.33
38.87%
dividend yield
earnings yield
-0.83
-
-0.27
67.69%
-0.21
21.20%
-1.27
498.80%
-5.45
329.35%
-0.07
98.77%
-0.01
89.42%
-0.01
16.99%
0.00
127.86%
-0.03
2,098.58%
-0.12
253.08%
enterprise value
-19.17M
-
293.82M
1,632.44%
328.13M
11.68%
100.01M
69.52%
76.24M
23.77%
1.79B
2,242.16%
3.46B
93.59%
5.97B
72.68%
9.73B
62.94%
3.13B
67.81%
2.28B
27.22%
enterprise value over ebitda
0.41
-
-3.88
1,036.93%
-4.76
22.46%
-1.28
73.05%
-1.21
5.47%
-40.01
3,203.19%
-206.72
416.69%
-750.19
262.90%
429.36
157.23%
-101.75
123.70%
-19.27
81.06%
ev to operating cash flow
0.40
-
-4.79
1,292.35%
-5.58
16.64%
-1.63
70.72%
-1.15
29.49%
-214.65
18,520.15%
82.49
138.43%
241.97
193.33%
87.34
63.90%
62.04
28.97%
-71.63
215.46%
ev to sales
-0.66
-
5.91
993.99%
4.50
23.78%
1.19
73.65%
0.71
40.31%
9.71
1,270.66%
9.54
1.75%
11.97
25.42%
13.84
15.65%
3.91
71.77%
3.05
22.01%
free cash flow per share
-182.75
-
-28.34
84.49%
-22.34
21.18%
-22.93
2.66%
-12.66
44.81%
-0.23
98.14%
0.38
262.73%
-0.13
132.71%
1.39
1,215.35%
0.12
91.60%
-1.28
1,196.33%
free cash flow yield
-0.71
-
-0.22
68.53%
-0.19
15.24%
-1.07
463.90%
-5.36
402.83%
-0.01
99.88%
0.01
203.66%
-0.00
120.38%
0.01
808.99%
0.00
71.88%
-0.04
1,765.99%
graham net net
312.51
-
11.64
96.28%
9.95
14.53%
-14.98
250.63%
-14.31
4.51%
1.88
113.12%
1.79
4.58%
3.74
109.00%
4.27
14.10%
2.27
46.84%
-0.20
108.80%
graham number
1.38K
-
134.27
90.25%
111.20
17.19%
34.51
68.97%
38.55
11.72%
12.50
67.57%
5.63
54.95%
8.73
54.96%
6.18
29.17%
15.09
144.01%
19.29
27.88%
income quality
0.76
-
0.77
2.04%
0.81
5.14%
0.73
9.66%
0.91
23.53%
0.07
92.51%
-1.69
2,595.15%
-0.72
57.62%
7.15
1,097.08%
-0.53
107.46%
0.14
126.79%
intangibles to total assets
0.02
-
0.02
37.90%
0.02
26.45%
0.02
5.88%
0.02
3.73%
0.01
64.15%
0.00
56.50%
0.01
415.83%
0.01
40.35%
0.00
40.05%
0.00
33.70%
interest coverage
-10.50
-
-19.40
84.79%
-18.45
4.90%
-13.68
25.85%
-5.55
59.42%
-5.88
6.03%
-214.38
3,542.97%
-0.65
99.69%
2.04
411.91%
-14.33
801.74%
-30.83
115.13%
interest debt per share
143.52
-
14.33
90.02%
11.55
19.36%
27.70
139.74%
15.48
44.11%
0.16
98.98%
0.35
121.94%
3.94
1,027.42%
5.06
28.42%
6.61
30.61%
6.51
1.49%
inventory turnover
2.21
-
2.89
30.88%
2.64
8.86%
2.86
8.50%
2.35
17.79%
4.73
100.91%
3.43
27.53%
3.74
9.18%
4.76
27.39%
3.49
26.66%
2.41
31.13%
invested capital
0.32
-
0.54
66.14%
0.47
13.35%
-13.32
2,949.86%
-2.63
80.29%
0.10
-
0.62
496.24%
0.73
16.56%
0.95
31.36%
1.33
38.87%
market cap
75.82M
-
295.55M
289.83%
341.55M
15.56%
65.73M
80.76%
13.40M
79.62%
1.83B
13,540.07%
3.49B
90.84%
5.84B
67.32%
9.48B
62.50%
2.88B
69.59%
1.92B
33.35%
net current asset value
102.31M
-
38.86M
62.02%
45.33M
16.66%
-26.23M
157.85%
-60.34M
130.06%
112.87M
287.06%
145.01M
28.48%
287.13M
98.00%
339.50M
18.24%
237.14M
30.15%
108.96M
54.05%
net debt to ebitda
2.05
-
0.02
98.88%
0.19
747.59%
-0.44
325.86%
-1.00
127.30%
0.94
193.87%
1.84
96.49%
-16.80
1,012.54%
10.75
163.97%
-8.04
174.79%
-3.02
62.46%
net income per share
-214.61
-
-34.17
84.08%
-25.04
26.72%
-27.30
9.01%
-12.86
52.87%
-2.55
80.20%
-0.42
83.39%
-0.56
33.25%
0.25
143.83%
-1.47
696.84%
-3.43
132.35%
operating cash flow per share
-162.33
-
-26.37
83.75%
-20.32
22.96%
-20.01
1.52%
-11.65
41.78%
-0.17
98.52%
0.72
514.38%
0.40
43.53%
1.77
337.01%
0.79
55.49%
-0.49
162.24%
payables turnover
9.71
-
2.36
75.67%
2.42
2.45%
3.14
29.67%
2.83
9.95%
2.70
4.34%
9.47
250.37%
13.38
41.29%
11.65
12.96%
6.97
40.21%
7.66
10.02%
receivables turnover
5.47
-
6.50
18.69%
5.18
20.23%
7.54
45.49%
5.17
31.38%
5.22
0.96%
7.78
48.86%
6.07
21.97%
6.35
4.59%
6.98
10.04%
7.08
1.42%
research and ddevelopement to revenue
0.38
-
0.32
16.85%
0.23
26.68%
0.22
4.12%
0.19
13.99%
0.16
17.22%
0.12
21.52%
0.13
2.16%
0.13
2.77%
0.17
32.56%
0.23
30.69%
return on tangible assets
-0.40
-
-0.76
93.14%
-0.59
22.99%
-0.75
28.15%
-0.78
3.11%
-0.60
23.17%
-0.08
87.27%
-0.05
36.14%
0.02
135.66%
-0.09
620.93%
-0.23
159.68%
revenue per share
98.59
-
21.37
78.33%
25.19
17.90%
27.56
9.40%
18.95
31.22%
3.82
79.84%
6.19
62.10%
8.18
32.08%
11.16
36.39%
12.49
11.97%
11.51
7.86%
roe
-0.55
-
-1.46
166.66%
-1.14
21.70%
14.08
1,333.91%
2.51
82.20%
-0.93
137.28%
-0.13
86.41%
-0.09
26.07%
0.04
138.29%
-0.22
698.26%
-0.71
230.11%
roic
-0.35
-
-0.90
159.72%
-0.74
17.80%
-1.07
44.20%
-1.33
24.31%
-0.34
74.39%
-0.07
79.02%
-0.01
82.96%
0.01
190.77%
-0.06
672.36%
-0.27
333.79%
sales general and administrative to revenue
1.51
-
1.08
28.57%
0.98
8.90%
0.80
18.35%
shareholders equity per share
392.72
-
23.45
94.03%
21.95
6.41%
-1.94
108.83%
-5.13
164.82%
2.73
153.12%
3.33
22.18%
6.01
80.22%
6.87
14.47%
6.86
0.24%
4.83
29.61%
stock based compensation to revenue
0.15
-
0.30
96.29%
0.18
40.39%
0.14
23.01%
0.12
15.20%
0.13
10.00%
0.16
24.16%
0.12
26.92%
0.09
26.20%
0.11
22.61%
0.12
11.14%
tangible asset value
112.84M
-
52.13M
53.80%
61.36M
17.70%
-7.71M
112.57%
-30.61M
296.90%
130.15M
525.24%
194.20M
49.22%
357.50M
84.09%
426.48M
19.29%
435.32M
2.07%
310.86M
28.59%
tangible book value per share
383.55
-
22.40
94.16%
21.22
5.29%
-2.52
111.89%
-5.39
113.73%
2.70
150.16%
3.32
22.75%
5.86
76.59%
6.77
15.49%
6.79
0.25%
4.78
29.50%
working capital
134.39M
-
72.66M
45.94%
80.46M
10.75%
60.62M
24.67%
28.07M
53.69%
121.60M
333.18%
176.75M
45.35%
533.38M
201.78%
679.66M
27.43%
684.69M
0.74%
552.73M
19.27%

All numbers in (except ratios and percentages)